Lifeward (LFWD) Competitors $0.76 -0.02 (-2.80%) As of 10:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock LFWD vs. POCI, CLGN, STRR, COCH, CTCX, PETV, VVOS, RVP, ICU, and NRXSShould you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include Precision Optics (POCI), CollPlant Biotechnologies (CLGN), Star Equity (STRR), Envoy Medical (COCH), Carmell (CTCX), PetVivo (PETV), Vivos Therapeutics (VVOS), Retractable Technologies (RVP), SeaStar Medical (ICU), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry. Lifeward vs. Its Competitors Precision Optics CollPlant Biotechnologies Star Equity Envoy Medical Carmell PetVivo Vivos Therapeutics Retractable Technologies SeaStar Medical NeurAxis Precision Optics (NASDAQ:POCI) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Is POCI or LFWD more profitable? Precision Optics has a net margin of -32.84% compared to Lifeward's net margin of -121.80%. Precision Optics' return on equity of -54.03% beat Lifeward's return on equity.Company Net Margins Return on Equity Return on Assets Precision Optics-32.84% -54.03% -32.48% Lifeward -121.80%-137.91%-90.28% Which has preferable earnings and valuation, POCI or LFWD? Precision Optics has higher earnings, but lower revenue than Lifeward. Precision Optics is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecision Optics$19.10M1.79-$2.95M-$0.89-5.02Lifeward$25.66M0.46-$28.94M-$3.12-0.24 Which has more volatility & risk, POCI or LFWD? Precision Optics has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Do institutionals & insiders hold more shares of POCI or LFWD? 13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 13.0% of Precision Optics shares are owned by insiders. Comparatively, 2.7% of Lifeward shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend POCI or LFWD? Lifeward has a consensus target price of $9.00, suggesting a potential upside of 1,085.77%. Given Lifeward's stronger consensus rating and higher probable upside, analysts clearly believe Lifeward is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lifeward 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor POCI or LFWD? In the previous week, Precision Optics had 1 more articles in the media than Lifeward. MarketBeat recorded 2 mentions for Precision Optics and 1 mentions for Lifeward. Lifeward's average media sentiment score of 1.91 beat Precision Optics' score of 0.95 indicating that Lifeward is being referred to more favorably in the news media. Company Overall Sentiment Precision Optics Positive Lifeward Very Positive SummaryPrecision Optics beats Lifeward on 9 of the 16 factors compared between the two stocks. Get Lifeward News Delivered to You Automatically Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFWD vs. The Competition Export to ExcelMetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$11.92M$20.09B$32.22B$10.39BDividend YieldN/A3.54%3.17%4.64%P/E Ratio-0.2475.42453.0626.11Price / Sales0.4691.641,764.67124.93Price / CashN/A85.2637.6261.24Price / Book0.358.987.226.30Net Income-$28.94M$355.94M$809.16M$271.03M7 Day Performance34.84%-1.55%-0.57%-0.20%1 Month Performance20.48%7.25%6.40%5.77%1 Year Performance-75.28%82.52%24,153.37%27.62% Lifeward Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFWDLifeward2.9537 of 5 stars$0.76-2.8%$9.00+1,084.2%-75.2%$11.93M$25.66M-0.2460Positive NewsPOCIPrecision Optics0.5082 of 5 stars$4.45+1.3%N/A-24.5%$34.09M$19.10M-4.9980Positive NewsUpcoming EarningsGap UpCLGNCollPlant Biotechnologies2.6387 of 5 stars$2.63-0.2%$11.50+338.1%-40.8%$33.38M$2.40M-2.3270STRRStar Equity1.2367 of 5 stars$10.38+5.8%$5.00-51.8%+179.1%$28.64M$140.06M-7.981,300Positive NewsHigh Trading VolumeCOCHEnvoy Medical2.1464 of 5 stars$1.33-0.4%$9.25+598.1%-76.0%$28.52M$222K-0.9334News CoverageCTCXCarmellN/A$1.30-32.2%N/A+180.4%$27.18M$32.84K0.0014PETVPetVivoN/A$0.96+1.0%N/A+90.5%$26.87M$1.05M-2.1420News CoverageGap DownVVOSVivos Therapeutics2.6052 of 5 stars$3.42+1.0%$4.92+44.0%+3.4%$25.63M$14.39M-2.03160Positive NewsRVPRetractable Technologies1.3548 of 5 stars$0.82-0.1%N/A+14.9%$24.52M$38.16M-1.52240News CoveragePositive NewsICUSeaStar Medical0.3422 of 5 stars$0.87+3.2%N/A-86.5%$24.29M$140K-0.332News CoverageGap DownNRXSNeurAxis2.3551 of 5 stars$2.33-0.4%$7.00+200.4%-8.3%$23.00M$3.22M-1.2719 Related Companies and Tools Related Companies Precision Optics Competitors CollPlant Biotechnologies Competitors Star Equity Competitors Envoy Medical Competitors Carmell Competitors PetVivo Competitors Vivos Therapeutics Competitors Retractable Technologies Competitors SeaStar Medical Competitors NeurAxis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFWD) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredChina Targets MAGA In Stealth Trade War TacticsChina is deliberately targeting the economic backbone of conservative America - The very industries that supp...Goldco Precious Metals | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifeward Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifeward With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.